This study was undertaken to evaluate the antidiabetic effect of polyherbal formulation containing varied concentration of Phyllanthus emblica and Annona squamosa leaves extract in streptozotocin induced type 2 diabetic rats. The polyherbal formulation (HF1 and HF2)
Introduction
Diabetes mellitus is a group of metabolic disorders resulting from defects in insulin secretion or reduced sensitivity of the tissues to insulin action or both. It is characterized through the chronic high blood glucose which causes the glycation of body protein and thus could lead to severe complications. Some of these complications are polyuria, polyphagia, polydypsia, ketosis, retinopathy as well as cardiovascular disorders 1, 2 .
Diabetes mellitus is a major global health concerning with a creating major medical issues in management of diabetes 6, 7 .
Additionally most anti-diabetic drugs promote long-term weight gain. Thus, these drugs treat one of the key symptoms, hyperglycemia, but exacerbate weight gain and obesity which further contribute to the progression of type 2 diabetes.
Therefore, while these drugs are beneficial over the short-term, they are not optimal for the long-term health of type 2 diabetic patients. The most desirable situation would be the development of new types of anti-diabetic drugs that are either hypoglycaemic or anti-hyperglycemic without the side effect of promoting weight gain 8 . Therefore more research is required to develop new antihyperglycemic agents with high efficiency and low toxicity from traditional medicines. 
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Material and Methods
Plant material
The leaves of Phyllanthus emblica and Annona squamosa were collected from the outfield of Solan, Himachal Pradesh, India in 
Preparation of decoction
20 g of mixture of each formulation with 150 ml of distilled water were macerated at ambient temperature for 24 h. After 24 h the drug macerate was boiled for 45 min and filtered through muslin cloth to get a decoction. The volume of the decoction was adjusted such that 20 g of mixture gave 50 ml of the decoction.
Antidiabetic activity 2.3.1 Oral glucose tolerance test (OGTT) of herbal formulation
The oral glucose tolerance test was performed in overnight fasted (18 hours) normal rats. The rats were divided into five groups (n = 6). Group I served as normal control rats, administered drinking water daily; Group II had glucose control rats; Group III rats were administered standard drug Glibenclamide (0.5 mg/kg); Group IV rats were administered HF1 (20 ml/kg body weight) orally and Group V rats were administered HF2 (20 ml/kg body weight) orally. Glucose (2 g/kg) was fed to rats of Group II to Group V, 30 minutes prior to the administration of the extracts and standard drug. Blood was withdrawn from the retro-orbital sinus after 0, 30, and 90 minutes of extract and standard drug administration, and the plasma obtained after centrifugation at 3000 rpm was estimated for fasting plasma glucose levels using a glucose oxidaseperoxidase glucose estimation kit [10] [11] [12] .
Induction of non-insulin dependent diabetes mellitus (NIDDM)
Non-insulin dependent diabetes mellitus was induced in overnight fasted adult rats weighing 170 -220 g by a single intraperitoneal injection of 60 mg/kg Streptozotocin, 15 minutes after i.p. administration of 120 mg/kg of nicotinamide.
Streptozotocin was dissolved in a citrate buffer (pH 4.5) and nicotinamide was dissolved in normal saline. Hyperglycemia was confirmed by the elevated glucose levels in plasma, determined at 72 hours and then on day 7, after injection. The threshold value of fasting plasma glucose to diagnose diabetes was taken as > 125 mg/dl. Only those rats that were found to have permanent NIDDM were used for the study.
Experimental design 2.3.3.1 Evaluation of antidiabetic activity of herbal formulation
The animals were segregated into five groups of six rats each.
The extract was administered for 28 days. Group I served as normal control rats, administered drinking water daily for 28 days; Group II had diabetic control rats, administered drinking water daily for 28 days; Group III diabetic rats were administered standard drug Glibenclamide (0.5 mg/kg); Group IV rats were administered HF1 (20 ml/kg body weight) and 
Estimation of biochemical parameters
The biochemical parameters were determined on day 28 after the animals were sacrificed by cervical dislocation. Total cholesterol, triglycerides (TGL), high-density lipoprotein (HDL) and low-density lipoprotein (LDL), were determined by the glucose oxidase method, using an auto-analyzer [13] [14] [15] .
Statistical analysis
The results are expressed as mean ± SD of six independent experiments. Statistical significance between the groups was evaluated by one-way analysis of variance (ANOVA) followed by Dunet's test. A P < 0.05 value was considered as statistically significant.
Results
Oral glucose tolerance effects of polyherbal formulation
The effects of polyherbal formulations on the plasma glucose level are demonstrated in table 2. The rise in glucose level was observed in glucose control, polyherbal formulation (HF1 and HF2) treated and standard group animals after the administration of glucose. The animals treated with polyherbal formulation, there was a significant reduction in plasma glucose level was observed compared to control group animals. In addition significant decrease in plasma glucose level was noted in glibenclamide treated group.
Effect on non-insulin dependent diabetes mellitus of polyherbal formulation
Induction of diabetes in experimental rats was confirmed by the presence of a high fasting plasma glucose level. 
Anti-hyperlipidaemic activity of polyherbal formulation
The outcomes of lipid profiles in control and experimental rats are exhibited in table 4. The animals of diabetic control showed significant increase in serum TGL, total cholesterol and LDL while increase in HDL when compared with normal animals.
The animals treated with glibenclamide also reduced TGL, total cholesterol, LDL, and increased HDL compared to diabetic control group. The polyherbal formulation (HF1 and HF2) treated animals showed significant decrease in total cholesterol, LDL, Triglycerides and significant increase in HDL. All these effects were observed on day 28. The outcome of lipid profile demonstrated that HF2 produces maximum antihyperlipidaemic activity on compared with HF1. 
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